Insider Transactions in Q4 2025 at Tarsus Pharmaceuticals, Inc. (TARS)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 24
2025
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Indirect |
6,000
-0.35%
|
$492,000
$82.98 P/Share
|
|
Dec 16
2025
|
Dianne C. Whitfield Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
7,397
-15.96%
|
$591,760
$80.1 P/Share
|
|
Dec 16
2025
|
Seshadri Neervannan Chief Operating Officer |
BUY
Bona fide gift
|
Indirect |
475
+50.0%
|
-
|
|
Dec 16
2025
|
Seshadri Neervannan Chief Operating Officer |
SELL
Bona fide gift
|
Direct |
950
-1.19%
|
-
|
|
Dec 16
2025
|
Elizabeth Yeu Lin Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,078
-8.65%
|
$164,162
$79.5 P/Share
|
|
Dec 15
2025
|
Elizabeth Yeu Lin Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,819
+22.11%
|
-
|
|
Dec 15
2025
|
William J Phd Link Director |
SELL
Open market or private sale
|
Indirect |
10,446
-77.19%
|
$846,126
$81.11 P/Share
|
|
Dec 15
2025
|
William J Phd Link Director |
SELL
Open market or private sale
|
Direct |
12,500
-3.03%
|
$1,012,500
$81.65 P/Share
|
|
Dec 04
2025
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Bona fide gift
|
Direct |
51,885
-96.74%
|
-
|